These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37839636)

  • 61. Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation.
    Mu H; Yu G; Li H; Wang M; Cui Y; Zhang T; Song T; Liu C
    Cell Oncol (Dordr); 2021 Oct; 44(5):1151-1166. PubMed ID: 34339013
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gamma-secretase complex-dependent intramembrane proteolysis of CD147 regulates the Notch1 signaling pathway in hepatocellular carcinoma.
    Yong YL; Zhang RY; Liu ZK; Wei D; Shang YK; Wu J; Zhang ZY; Li C; Chen ZN; Bian H
    J Pathol; 2019 Oct; 249(2):255-267. PubMed ID: 31215640
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Spatial localization of the JAG1/Notch1/osteopontin cascade modulates extrahepatic metastasis in hepatocellular carcinoma.
    Xue TC; Zou JH; Chen RX; Cui JF; Tang ZY; Ye SL
    Int J Oncol; 2014 Nov; 45(5):1883-90. PubMed ID: 25176314
    [TBL] [Abstract][Full Text] [Related]  

  • 64. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Blockade of the Notch1/Jagged1 pathway in Kupffer cells aggravates ischemia-reperfusion injury of orthotopic liver transplantation in mice.
    Bai H; Wen J; Gong JP; Wu H; Yuan FC; Cao D; Wu YK; Lai X; Wang MH
    Autoimmunity; 2019 Jun; 52(4):176-184. PubMed ID: 31322442
    [TBL] [Abstract][Full Text] [Related]  

  • 66. TET3 Mediates Alterations in the Epigenetic Marker 5hmC and Akt pathway in Steroid-Associated Osteonecrosis.
    Zhao J; Ma XL; Ma JX; Sun L; Lu B; Wang Y; Xing GS; Wang Y; Dong BC; Xu LY; Kuang MJ; Fu L; Bai HH; Ma Y; Jin WL
    J Bone Miner Res; 2017 Feb; 32(2):319-332. PubMed ID: 27627619
    [TBL] [Abstract][Full Text] [Related]  

  • 67. SCARF1 promotes M2 polarization of Kupffer cells via calcium-dependent PI3K-AKT-STAT3 signalling to improve liver transplantation.
    Xu XS; Feng ZH; Cao D; Wu H; Wang MH; Li JZ; Gong JP
    Cell Prolif; 2021 Apr; 54(4):e13022. PubMed ID: 33686740
    [TBL] [Abstract][Full Text] [Related]  

  • 68. C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells.
    Li SG; Shi QW; Yuan LY; Qin LP; Wang Y; Miao YQ; Chen Z; Ling CQ; Qin WX
    J Exp Clin Cancer Res; 2018 Mar; 37(1):51. PubMed ID: 29523159
    [TBL] [Abstract][Full Text] [Related]  

  • 69. IFITM3 upregulates c-myc expression to promote hepatocellular carcinoma proliferation via the ERK1/2 signalling pathway.
    Min J; Hu J; Luo C; Zhu J; Zhao J; Zhu Z; Wu L; Yuan R
    Biosci Trends; 2020 Jan; 13(6):523-529. PubMed ID: 31852866
    [TBL] [Abstract][Full Text] [Related]  

  • 70. TXNDC9 promotes hepatocellular carcinoma progression by positive regulation of MYC-mediated transcriptional network.
    Chen D; Zou J; Zhao Z; Tang X; Deng Z; Jia J; Liu S
    Cell Death Dis; 2018 Oct; 9(11):1110. PubMed ID: 30382079
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nogo-B fosters HCC progression by enhancing Yap/Taz-mediated tumor-associated macrophages M2 polarization.
    Zhao X; Wang X; You Y; Wen D; Feng Z; Zhou Y; Que K; Gong J; Liu Z
    Exp Cell Res; 2020 Jun; 391(1):111979. PubMed ID: 32246992
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis.
    Jiang Y; Han Q; Zhao H; Zhang J
    J Exp Clin Cancer Res; 2021 Jan; 40(1):13. PubMed ID: 33407720
    [TBL] [Abstract][Full Text] [Related]  

  • 73. EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A.
    Wang K; Jiang X; Jiang Y; Liu J; Du Y; Zhang Z; Li Y; Zhao X; Li J; Zhang R
    J Exp Clin Cancer Res; 2023 Nov; 42(1):320. PubMed ID: 38008711
    [TBL] [Abstract][Full Text] [Related]  

  • 74. c-Src promotes the growth and tumorigenesis of hepatocellular carcinoma via the Hippo signaling pathway.
    Yang J; Zhang X; Liu L; Yang X; Qian Q; Du B
    Life Sci; 2021 Jan; 264():118711. PubMed ID: 33186566
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression.
    Cheng Q; Yuan F; Lu F; Zhang B; Chen T; Chen X; Cheng Y; Li N; Ma L; Tong T
    Oncotarget; 2015 Mar; 6(7):4733-44. PubMed ID: 25749381
    [TBL] [Abstract][Full Text] [Related]  

  • 76. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 77. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.
    Zhou Y; Lin F; Wan T; Chen A; Wang H; Jiang B; Zhao W; Liao S; Wang S; Li G; Xu Z; Wang J; Zhang J; Ma H; Lin D; Li Q
    Theranostics; 2021; 11(12):5926-5938. PubMed ID: 33897890
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hepatitis B virus X protein activates Notch signaling by its effects on Notch1 and Notch4 in human hepatocellular carcinoma.
    Gao J; Xiong Y; Wang Y; Wang Y; Zheng G; Xu H
    Int J Oncol; 2016 Jan; 48(1):329-37. PubMed ID: 26530164
    [TBL] [Abstract][Full Text] [Related]  

  • 79. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
    Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
    Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
    [TBL] [Abstract][Full Text] [Related]  

  • 80. TET3-mediated DNA demethylation modification activates SHP2 expression to promote endometrial cancer progression through the EGFR/ERK pathway.
    Xue F; Liu L; Tao X; Zhu W
    J Gynecol Oncol; 2024 Feb; ():. PubMed ID: 38456588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.